JP6180520B2 - ロチゴチンを含有した経皮吸収製剤(Transdermalcompositioncomprisingrotigotine) - Google Patents
ロチゴチンを含有した経皮吸収製剤(Transdermalcompositioncomprisingrotigotine) Download PDFInfo
- Publication number
- JP6180520B2 JP6180520B2 JP2015520068A JP2015520068A JP6180520B2 JP 6180520 B2 JP6180520 B2 JP 6180520B2 JP 2015520068 A JP2015520068 A JP 2015520068A JP 2015520068 A JP2015520068 A JP 2015520068A JP 6180520 B2 JP6180520 B2 JP 6180520B2
- Authority
- JP
- Japan
- Prior art keywords
- rotigotine
- crystallization
- sensitive adhesive
- inhibitor
- pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Description
結晶防止剤を含有したパッチの製造及び結晶評価
下記表1により3種の結晶防止剤を添加したロチゴチン経皮剤を製造した。
結晶防止剤の比率別パッチ製造及び結晶評価
結晶防止剤の比率によるロチゴチンの結晶程度を測定した。
結晶防止剤の比率別パッチのIn vitroでの透過実験
Claims (8)
- ロチゴチンを結晶防止剤と混合する段階を含むロチゴチンの結晶防止方法であって、
前記結晶防止剤がオレイン酸であり、
前記ロチゴチンと前記結晶防止剤を10:0.1〜10の重量比で混合して、前記ロチゴチンの結晶化を抑制し、
但し、ロチゴチンをポリビニルピロリドンと混合することは含まない、前記方法。 - ロチゴチンと結晶防止剤を有効成分として含む経皮吸収製剤であって、
前記結晶防止剤がオレイン酸であり、
前記ロチゴチンと前記結晶防止剤が10:0.1〜10の重量比で混合されて、前記ロチゴチンの結晶化が抑制され、
但し、ポリビニルピロリドンを含まない、前記経皮吸収製剤。 - ロチゴチンを結晶防止剤と混合することを含む経皮吸収製剤の製造方法であって、
前記結晶防止剤がオレイン酸であり、
前記ロチゴチンと前記結晶防止剤を10:0.1〜10の重量比で混合して、前記ロチゴチンの結晶化を抑制し、
但し、ロチゴチンをポリビニルピロリドンと混合することは含まない、前記方法。 - 前記ロチゴチンをさらにエタノールと混合する、請求項3に記載の方法。
- ロチゴチン、結晶防止剤、及び粘着剤を含む薬剤含有粘着剤層と、
前記薬剤含有粘着剤層を支持する基材とを含む経皮治療システムであって、
前記結晶防止剤がオレイン酸であり、
前記薬剤含有粘着剤層が、前記ロチゴチン、前記結晶防止剤、及び前記粘着剤を、10:0.1〜10:40〜96.5の重量比で含み、前記ロチゴチンの結晶化が抑制され、
但し、ポリビニルピロリドンを含まない、前記経皮治療システム。 - 前記粘着剤は、シリコーン系粘着剤、ゴム系粘着剤、アクリル系粘着剤及びエチレン−ビニルアセテート粘着剤からなる群より選ばれた粘着剤であることを特徴とする請求項5に記載のシステム。
- 前記ゴム系粘着剤はスチレン系粘着剤であることを特徴とする請求項6に記載のシステム。
- 前記結晶防止剤は、前記薬剤含有粘着剤層の総重量に対して、0.1重量%より多く、37重量%以下で含まれることを特徴とする請求項5に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2012-0073295 | 2012-07-05 | ||
KR20120073295 | 2012-07-05 | ||
PCT/KR2013/006001 WO2014007579A1 (ko) | 2012-07-05 | 2013-07-05 | 로티고틴을 함유한 경피흡수제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015522012A JP2015522012A (ja) | 2015-08-03 |
JP6180520B2 true JP6180520B2 (ja) | 2017-08-16 |
Family
ID=49882267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015520068A Active JP6180520B2 (ja) | 2012-07-05 | 2013-07-05 | ロチゴチンを含有した経皮吸収製剤(Transdermalcompositioncomprisingrotigotine) |
Country Status (9)
Country | Link |
---|---|
US (1) | US20150118282A1 (ja) |
EP (1) | EP2870962B1 (ja) |
JP (1) | JP6180520B2 (ja) |
KR (1) | KR101558042B1 (ja) |
AU (1) | AU2013285733B2 (ja) |
BR (1) | BR112015000107B1 (ja) |
CA (1) | CA2878376C (ja) |
MX (1) | MX2015000049A (ja) |
WO (1) | WO2014007579A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014193190A1 (ko) * | 2013-05-30 | 2014-12-04 | 에스케이케미칼 (주) | 로티고틴과 지방산 및 스티렌 점착제를 함유한 경피치료시스템 |
CN110638792B (zh) * | 2019-10-16 | 2022-04-19 | 沈阳药科大学 | 一种罗替戈汀经皮吸收贴剂及其制备和应用 |
US20230310339A1 (en) * | 2020-09-03 | 2023-10-05 | Kaneka Corporation | Patch and production method thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0942727A1 (en) * | 1996-04-08 | 1999-09-22 | Sano Corporation | Transdermal delivery device for azapirone compounds |
DE19814084B4 (de) | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
DE60100595T2 (de) * | 2001-05-08 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Verbessertes transdermales therapeutisches System zur Behandlung von Morbus Parkinson |
DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
US20040005339A1 (en) * | 2002-06-28 | 2004-01-08 | Shojaei Amir H. | Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
US8246979B2 (en) * | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
EP1386605A1 (en) * | 2002-07-30 | 2004-02-04 | Schwarz Pharma Ag | Improved transdermal delivery system for the administration of rotigotine |
DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
US20090305943A1 (en) * | 2006-07-18 | 2009-12-10 | Sven Siegel | Cyclodextrin blends with crystal growth inhibitors |
JP5243254B2 (ja) * | 2006-10-11 | 2013-07-24 | 久光製薬株式会社 | 結晶含有貼付剤 |
JP5227535B2 (ja) * | 2007-04-19 | 2013-07-03 | 久光製薬株式会社 | 貼付剤 |
CN101147739B (zh) * | 2007-07-06 | 2010-12-08 | 北京康倍得医药技术开发有限公司 | 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂 |
JP5224163B2 (ja) * | 2007-07-24 | 2013-07-03 | コスメディ製薬株式会社 | 経皮吸収テープ製剤 |
US20090202647A1 (en) * | 2008-02-11 | 2009-08-13 | Mayur Devjibhai Khunt | Solid form of racemic rotigotine |
JP5547065B2 (ja) * | 2008-05-15 | 2014-07-09 | 久光製薬株式会社 | パロノセトロンを含有する経皮吸収製剤 |
ME03053B (me) | 2009-12-22 | 2018-10-20 | Ucb Biopharma Sprl | Polivinilpirolidon za stabilizaciju čvrste disperzije nekristalnog oblika rotigotina |
AU2011334494B2 (en) * | 2010-11-25 | 2015-11-05 | Geneora Pharma (Shijiazhuang) Co., Ltd. | Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative |
EP2457565A1 (de) * | 2010-11-29 | 2012-05-30 | Ratiopharm GmbH | Transdermales therapeutisches System enthaltend Rotigotin |
-
2013
- 2013-07-05 EP EP13812795.6A patent/EP2870962B1/en not_active Not-in-force
- 2013-07-05 KR KR1020130079198A patent/KR101558042B1/ko active IP Right Grant
- 2013-07-05 AU AU2013285733A patent/AU2013285733B2/en active Active
- 2013-07-05 WO PCT/KR2013/006001 patent/WO2014007579A1/ko active Application Filing
- 2013-07-05 MX MX2015000049A patent/MX2015000049A/es unknown
- 2013-07-05 BR BR112015000107-6A patent/BR112015000107B1/pt active IP Right Grant
- 2013-07-05 JP JP2015520068A patent/JP6180520B2/ja active Active
- 2013-07-05 CA CA2878376A patent/CA2878376C/en active Active
-
2015
- 2015-01-05 US US14/589,851 patent/US20150118282A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2878376C (en) | 2018-08-07 |
US20150118282A1 (en) | 2015-04-30 |
WO2014007579A1 (ko) | 2014-01-09 |
JP2015522012A (ja) | 2015-08-03 |
KR101558042B1 (ko) | 2015-10-07 |
BR112015000107B1 (pt) | 2022-07-19 |
EP2870962A4 (en) | 2016-03-02 |
AU2013285733A1 (en) | 2015-02-05 |
BR112015000107A2 (pt) | 2019-10-08 |
EP2870962B1 (en) | 2018-09-12 |
EP2870962A1 (en) | 2015-05-13 |
AU2013285733B2 (en) | 2016-11-10 |
KR20140006727A (ko) | 2014-01-16 |
CA2878376A1 (en) | 2014-01-09 |
MX2015000049A (es) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4883220B2 (ja) | ロチゴチン含有組成物及びその使用並びにこの組成物を含む経皮貼付剤 | |
US9877948B2 (en) | Rotigotine-containing transdermal absorption preparation with improved stability | |
WO2009139411A1 (ja) | パロノセトロンを含有する経皮吸収製剤 | |
NO335200B1 (no) | Matriks og innretning for transdermal administrering av rotigotinbase, anvendelse og fremgangsmåte for fremstilling derav. | |
TWI742331B (zh) | 含羅替戈汀之貼附劑 | |
JP6180520B2 (ja) | ロチゴチンを含有した経皮吸収製剤(Transdermalcompositioncomprisingrotigotine) | |
KR101558043B1 (ko) | 로티고틴 함유 경피흡수제제 | |
WO2021098791A1 (zh) | 一种含有美金刚的透皮贴剂 | |
EP2068847B1 (en) | Preparation and composition of meloxicam transdermal drug delivery system | |
JP6373061B2 (ja) | 経皮投与製剤 | |
JP7399633B2 (ja) | 経皮吸収型製剤の製造方法 | |
KR101686987B1 (ko) | 로티고틴과 지방산 및 스티렌 점착제를 함유한 경피치료시스템 | |
TW202102217A (zh) | 藥物對生物體具優異吸收性且亦具有優異化學安定性之醫藥組成物 | |
TW202112366A (zh) | 含羅替戈汀之貼附劑 | |
JP2004075537A (ja) | エストラジオール含有貼付剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160617 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170321 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170621 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170704 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170718 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6180520 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |